In clinical trials: People achieved an average weight loss of 15% in just over a year In studies lasting 7 months to just over a year, semaglutide helped most people with type 2 diabetes (66-80%) reach their target HbA1c of less than 7% The medication also helped people with heart disease by reducing their risk of heart attacks, strokes, and heart-related deaths by 20% Side effects Like most medications, semaglutide can cause side effects
The formulation may further comprise a buffer system, preservative(s), tonicity agent(s), chelating agent(s), stabilizers and surfactants
While the impact of GLP-1 on health outcomes for diabetes and obesity has been revolutionary, payors are actively looking to mitigate projected health costs
The entire journey is handled through their telehealth platform
As a result, individuals taking semaglutide often experience a decrease in food intake, which contributes to weight loss